We are live on ! Find out more
AEMD icon

Aethlon Medical
AEMD

2 hedge funds and large institutions have $437K invested in Aethlon Medical in 2017 Q2 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 1 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 2 → 2 (0)

0% less ownership

Funds ownership: 0% → 0% (-0%)

49% less capital invested

Capital invested by funds: $851K → $437K (-$414K)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
2
Holders Change
–
Holders Change %
0%
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
-$129K
2
Bank of New York Mellon
Bank of New York Mellon
New York
-$56K
3
BC
Bartlett & Co
Ohio
-$13K

AEMD Hedge Fund Activity: Q2 2017 in Review

2 of the 4,022 institutional investors tracked by Wall St. Rank reported a position in Aethlon Medical (AEMD) for Q2 2017, worth a combined $437K — down 49% from $851K a quarter earlier.

Fund positioning in AEMD was balanced in Q2 2017: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 1 trimmed.

The largest seller was Vanguard Group, cutting an estimated $129K.

  • 2 institutional investors held Aethlon Medical (AEMD) as of Q2 2017, unchanged from Q1 2017.
  • Funds reported $437K of Aethlon Medical stock for Q2 2017, down 49% quarter-over-quarter.
  • 0 funds opened new Aethlon Medical positions in Q2 2017 and 0 closed out.
  • The largest Aethlon Medical seller in Q2 2017 was Vanguard Group, an estimated $129K sold.

Based on aggregated 13F filings for Q2 2017.